mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.01 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.01 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |